CHARACTERIZATION OF HUMAN OVARIAN EPITHELIAL TUMORS (EX-VIVO) BY PROTON MAGNETIC-RESONANCE SPECTROSCOPY

被引:31
|
作者
MACKINNON, WB [1 ]
RUSSELL, P [1 ]
MAY, GL [1 ]
MOUNTFORD, CE [1 ]
机构
[1] ROYAL PRINCE ALFRED HOSP, DEPT ANAT PATHOL, CAMPERDOWN, NSW, AUSTRALIA
关键词
EX VIVO; HUMAN OVARY; H-1; MRS;
D O I
10.1046/j.1525-1438.1995.05030211.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Proton magnetic resonance spectroscopy (H-1 MRS) offers an alternative investigational modality that will assist current pathologic techniques in the diagnosis of human ovarian epithelial tumors. Histologically normal human ovarian tissue (n=12) was compared with ovarian benign fibromas (n=3) and surface epithelial-stromal tumors (benign, n=18; proliferating, n = 9; frankly malignant, n = 30) ex vivo by H-1 MRS. The distinction between carcinomatous and benign or normal tissue (P<0.0001; Student's t-test) was made on one-dimensional (1-D) 1H MR spectra utilizing differences in resonance intensities of cellular lipid, creatine/phosphocreatine and lysine. The sensitivity and specificity of the test were 87% and 91%, respectively. Two-dimensional (2-D) MRS of carcinomatous biopsies showed multiple crosspeaks attributable to cell-surface fucosylation that correlated with tumor grade and loss of cellular differentiation. The multiple fucose crosspeaks were absent in spectra from normal ovary and benign tumors. The distinction between carcinomatous and normal or benign tissue based on MR-visible fucosylation gave a sensitivity and specificity of 88% and 97%, respectively. Proliferating tumors exhibited a range of cell-surface fucosylation patterns indicative of malignant potential.
引用
收藏
页码:211 / 221
页数:11
相关论文
共 50 条
  • [1] PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF HUMAN-TUMORS INVIVO
    BARANY, M
    KNOP, RH
    VICTOR, TA
    VENKATASUBRAMANIAN, PN
    MOK, E
    WILBUR, AC
    MAFEE, MF
    TUMORDIAGNOSTIK & THERAPIE, 1988, 9 (04) : 169 - 169
  • [2] PROTON MAGNETIC-RESONANCE AND HUMAN CERVICAL NEOPLASIA .2. EX-VIVO CHEMICAL-SHIFT MICROIMAGING
    KUNNECKE, B
    DELIKATNY, EJ
    RUSSELL, P
    HUNTER, JC
    MOUNTFORD, CE
    JOURNAL OF MAGNETIC RESONANCE SERIES B, 1994, 104 (02): : 135 - 142
  • [3] CHARACTERIZATION OF TRANSFORMED-CELLS AND TUMORS BY PROTON NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY
    MOUNTFORD, CE
    GROSSMAN, G
    REID, G
    FOX, RM
    CANCER RESEARCH, 1982, 42 (06) : 2270 - 2276
  • [4] IN-VIVO PROTON MAGNETIC-RESONANCE SPECTROSCOPY DETECTION OF HUMAN ALCOHOL TOLERANCE
    CHIU, TM
    MENDELSON, JH
    WOODS, BT
    TEOH, SK
    LEVISOHN, L
    MELLO, NK
    MAGNETIC RESONANCE IN MEDICINE, 1994, 32 (04) : 511 - 516
  • [5] Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy
    Tzika, AA
    Cheng, LL
    Goumnerova, L
    Madsen, JR
    Zurakowski, D
    Astrakas, LG
    Zarifi, MK
    Scott, RM
    Anthony, DC
    Gonzalez, RG
    Black, PM
    JOURNAL OF NEUROSURGERY, 2002, 96 (06) : 1023 - 1031
  • [6] In vivo proton magnetic resonance spectroscopy of brain tumors
    Fountas, KN
    Kapsalaki, EZ
    Gotsis, SD
    Kapsalakis, JZ
    Smisson, HF
    Johnston, KW
    Robinson, JS
    Papadakis, N
    STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 2000, 74 (02) : 83 - 94
  • [7] PROTON MAGNETIC-RESONANCE CHARACTERIZATION OF BRAIN-TUMORS
    JEZERNIK, M
    SENTJURC, M
    SCHARA, M
    ACTA NEUROCHIRURGICA, 1983, 67 (1-2) : 1 - 9
  • [8] PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF PEDIATRIC BRAIN-TUMORS
    SUTTON, LN
    WANG, ZY
    GUSNARD, D
    LANGE, B
    PERILONGO, G
    BOGDAN, AR
    DETRE, JA
    RORKE, L
    ZIMMERMAN, RA
    NEUROSURGERY, 1992, 31 (02) : 195 - 202
  • [9] NONINVASIVE CHARACTERIZATION OF BRAIN-TUMOR BY IN-VIVO PROTON MAGNETIC-RESONANCE SPECTROSCOPY
    HARADA, M
    TANOUCHI, M
    NISHITANI, H
    MIYOSHI, H
    BANDOU, K
    KANNUKI, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (03): : 329 - 332
  • [10] PROTON MAGNETIC-RESONANCE SPECTROSCOPY
    MCQUARRIE, DA
    JOURNAL OF CHEMICAL EDUCATION, 1988, 65 (05) : 426 - 433